Tim Street<p>GLP1-RAs in Type 1 Diabetes: Dosing and Pharmacokinetics<br>As we discussed in the previous article, people are starting to use incretins as an adjunct therapy in the treatment of type 1 diabetes. All off label, of course.</p><p>Anyone familiar with these drugs will know that they are indicated to be injected once a wee<br><a href="https://www.diabettech.com/glp1-ra/glp1-ras-in-type-1-diabetes-dosing-and-pharmacokinetics/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">diabettech.com/glp1-ra/glp1-ra</span><span class="invisible">s-in-type-1-diabetes-dosing-and-pharmacokinetics/</span></a><br><a href="https://mastodonapp.uk/tags/GLP1RA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GLP1RA</span></a> <a href="https://mastodonapp.uk/tags/Dosing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Dosing</span></a> <a href="https://mastodonapp.uk/tags/Halflife" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Halflife</span></a> <a href="https://mastodonapp.uk/tags/Mounjaro" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Mounjaro</span></a> <a href="https://mastodonapp.uk/tags/Semaglutide" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Semaglutide</span></a> <a href="https://mastodonapp.uk/tags/Tirzepatide" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Tirzepatide</span></a> <a href="https://mastodonapp.uk/tags/variability" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>variability</span></a> <a href="https://mastodonapp.uk/tags/WeGovy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>WeGovy</span></a></p>